Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cimarex Energy Prices $750 Mln Of Senior Notes

RELATED NEWS
Trade XEC now with 

Cimarex Energy Co. (XEC: Quote) said Thursday that it has priced an offering of $750 million aggregate principal amount of senior notes due 2022, which will carry an interest rate of 5.875%.

This was an increase from the company's earlier plan to offer $650 million aggregate principal amount of senior unsecured notes due 2022

The notes were sold to the public at par.

Cimarex plans to use a portion of the net proceeds from the offering to purchase any and all of the outstanding $350 million aggregate principal amount of its 7.125% Senior Notes due 2017, pursuant to a separately announced tender offer and to redeem any of such outstanding notes not acquired in the tender offer.

The company plans to use the remaining net proceeds for general corporate purposes, including repayment of amounts outstanding under its revolving credit facility.

Click here to receive FREE breaking news email alerts for Cimarex Energy Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.